Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BRLI

Brilliant Acquisition (BRLI) Stock Price, News & Analysis

Brilliant Acquisition logo

About Brilliant Acquisition Stock (NASDAQ:BRLI)

Advanced Chart

Key Stats

Today's Range
$3.59
$9.15
50-Day Range
N/A
52-Week Range
N/A
Volume
370,983 shs
Average Volume
87,171 shs
Market Capitalization
$8.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Brilliant Acquisition Corporation operates as a blank check company. It focuses on acquiring; engaging in share exchange and share reconstruction; purchasing the assets; entering into contractual arrangements; and engaging in similar business combination with one or more businesses. The company was founded in 2019 and is based in Shanghai, China.

Receive BRLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brilliant Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BRLI Stock News Headlines

Marriott Bonvoy Brilliant Credit Card Review 2024
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Brilliant Acquisition Corp. Rt
See More Headlines

BRLI Stock Analysis - Frequently Asked Questions

Brilliant Acquisition Co. (NASDAQ:BRLI) posted its quarterly earnings results on Thursday, December, 18th. The medical research company reported $0.66 earnings per share for the quarter, topping analysts' consensus estimates of $0.63 by $0.03. The business's revenue for the quarter was up 18.4% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brilliant Acquisition investors own include OPKO Health (OPK), Alibaba Group (BABA), Biogen (BIIB), Bristol Myers Squibb (BMY), General Motors (GM), M&T Bank (MTB) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
12/18/2014
Today
6/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Management consulting services
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:BRLI
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$970 thousand
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($1.89) per share
Price / Book
-2.49

Miscellaneous

Free Float
548,000
Market Cap
$8.51 million
Optionable
Not Optionable
Beta
-0.12
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:BRLI) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners